Nonetheless, our report is the first to suggest that genetic polymorphisms and specific haplotypes in SLC22A1 and ABCB1 may contribute towards inter-individual and inter-ethnic variations in IM disposition in CML patients. Here, SLC22A1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.